Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,000 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes With Central or Hemiretinal Vein Occlusion Managed With Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical Trials.
Hendrick A, VanVeldhuisen PC, Scott IU, King J, Blodi BA, Ip MS, Khurana RN, Oden NL; SCORE2 Investigator Group. Hendrick A, et al. Among authors: king j. Am J Ophthalmol. 2021 Feb;222:185-193. doi: 10.1016/j.ajo.2020.08.030. Epub 2020 Aug 20. Am J Ophthalmol. 2021. PMID: 32828880 Free PMC article. Clinical Trial.
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL; Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group. Aref AA, et al. Among authors: king j. JAMA Ophthalmol. 2021 Dec 1;139(12):1285-1291. doi: 10.1001/jamaophthalmol.2021.4395. JAMA Ophthalmol. 2021. PMID: 34709363 Free PMC article. Clinical Trial.
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.
Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Study Investigator Group. Scott IU, et al. JAMA Ophthalmol. 2022 May 1;140(5):458-464. doi: 10.1001/jamaophthalmol.2022.0352. JAMA Ophthalmol. 2022. PMID: 35323843 Free PMC article. Clinical Trial.
Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study.
Borrego-Yaniz G, Ortiz-Fernández L, Madrid-Paredes A, Kerick M, Hernández-Rodríguez J, Mackie SL, Vaglio A, Castañeda S, Solans R, Mestre-Torres J, Khalidi N, Langford CA, Ytterberg S, Beretta L, Govoni M, Emmi G, Cimmino MA, Witte T, Neumann T, Holle J, Schönau V, Pugnet G, Papo T, Haroche J, Mahr A, Mouthon L, Molberg Ø, Diamantopoulos AP, Voskuyl A, Daikeler T, Berger CT, Molloy ES, Blockmans D, van Sleen Y, Iles M, Sorensen L, Luqmani R, Reynolds G, Bukhari M, Bhagat S, Ortego-Centeno N, Brouwer E, Lamprecht P, Klapa S, Salvarani C, Merkel PA, Cid MC, González-Gay MA, Morgan AW, Martin J, Márquez A; Spanish GCA Group; UK GCA Consortium; Vasculitis Clinical Research Consortium. Borrego-Yaniz G, et al. Lancet Rheumatol. 2024 May 8:S2665-9913(24)00064-X. doi: 10.1016/S2665-9913(24)00064-X. Online ahead of print. Lancet Rheumatol. 2024. PMID: 38734017
Small-angle scattering of complex fluids in flow.
Williams AP, King JP, Sokolova A, Tabor RF. Williams AP, et al. Among authors: king jp. Adv Colloid Interface Sci. 2024 Apr 26;328:103161. doi: 10.1016/j.cis.2024.103161. Online ahead of print. Adv Colloid Interface Sci. 2024. PMID: 38728771
Climate change, malaria and neglected tropical diseases: a scoping review.
Klepac P, Hsieh JL, Ducker CL, Assoum M, Booth M, Byrne I, Dodson S, Martin DL, Turner CMR, van Daalen KR, Abela B, Akamboe J, Alves F, Brooker SJ, Ciceri-Reynolds K, Cole J, Desjardins A, Drakeley C, Ediriweera DS, Ferguson NM, Gabrielli AF, Gahir J, Jain S, John MR, Juma E, Kanayson P, Deribe K, King JD, Kipingu AM, Kiware S, Kolaczinski J, Kulei WJ, Laizer TL, Lal V, Lowe R, Maige JS, Mayer S, McIver L, Mosser JF, Nicholls RS, Nunes-Alves C, Panjwani J, Parameswaran N, Polson K, Radoykova HS, Ramani A, Reimer LJ, Reynolds ZM, Ribeiro I, Robb A, Sanikullah KH, Smith DRM, Shirima GG, Shott JP, Tidman R, Tribe L, Turner J, Vaz Nery S, Velayudhan R, Warusavithana S, Wheeler HS, Yajima A, Abdilleh AR, Hounkpatin B, Wangmo D, Whitty CJM, Campbell-Lendrum D, Hollingsworth TD, Solomon AW, Fall IS. Klepac P, et al. Among authors: king jd. Trans R Soc Trop Med Hyg. 2024 May 10:trae026. doi: 10.1093/trstmh/trae026. Online ahead of print. Trans R Soc Trop Med Hyg. 2024. PMID: 38724044
7,000 results